On the role of RNA binding proteins in polyglutamine diseases: from pathogenesis to therapeutics

On the role of RNA binding proteins in polyglutamine diseases: from pathogenesis to therapeutics

Bibliographic Details
Main Authors:	André Conceição, Rebekah Koppenol, Clévio Nóbrega
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=12;spage=2695;epage=2696;aulast=Conceição

Similar Items

Polyglutamine disease: from pathogenesis to therapy.
by: Watson, L, et al.
Published: (2012)

Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias
by: Ricardo Afonso-Reis, et al.
Published: (2021-04-01)

Skeletal Muscle Pathogenesis in Polyglutamine Diseases
by: Caterina Marchioretti, et al.
Published: (2022-07-01)

Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics
by: Rodrigo Paulino, et al.
Published: (2023-04-01)

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
by: Toshihide Takeuchi, et al.
Published: (2017-10-01)

RNA therapy for polyglutamine neurodegenerative diseases.
by: Watson, L, et al.
Published: (2012)

RNA therapy for polyglutamine neurodegenerative diseases.
by: Watson, L, et al.
Published: (2012)

Structure of puromycin-sensitive aminopeptidase and polyglutamine binding.
by: Sowmya Madabushi, et al.
Published: (2023-01-01)

Editorial: The role of posttranslational modifications in polyglutamine diseases
by: Jonasz Jeremiasz Weber, et al.
Published: (2023-08-01)

Therapeutic gene silencing strategies for polyglutamine disorders.
by: Scholefield, J, et al.
Published: (2010)

Identification of Novel Therapeutic Targets for Polyglutamine Diseases That Target Mitochondrial Fragmentation
by: Annika Traa, et al.
Published: (2021-12-01)

Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias
by: Alexandra F. Putka, et al.
Published: (2023-02-01)

Molecular origin of polyglutamine aggregation in neurodegenerative diseases.
Published: (2005-08-01)

Polyglutamine Expanded Huntingtin Dramatically Alters the Genome-Wide Binding of HSF1
by: Riva, Laura, et al.
Published: (2014)

Extracellular Vesicles Physiological Role and the Particular Case of Disease-Spreading Mechanisms in Polyglutamine Diseases
by: Ricardo Moreira, et al.
Published: (2021-11-01)

Ion channels and neuronal excitability in polyglutamine neurodegenerative diseases
by: Martinez-Rojas Vladimir A., et al.
Published: (2022-03-01)

Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools
by: Marianna Karwacka, et al.
Published: (2022-02-01)

An engineered viral protease exhibiting substrate specificity for a polyglutamine stretch prevents polyglutamine-induced neuronal cell death.
by: Saravanan Sellamuthu, et al.
Published: (2011-01-01)

Development of mAb-based polyglutamine-dependent and polyglutamine length-independent huntingtin quantification assays with cross-site validation.
by: David F Fischer, et al.
Published: (2022-01-01)

Advances of research on the function of RNA binding proteins in the pathogenesis of thyroid carcinoma
by: ZHOU Mei-cen, LAN Ling, DENG Wei
Published: (2022-08-01)

CAG-encoded polyglutamine length polymorphism in the human genome
by: Hayden Michael R, et al.
Published: (2007-05-01)

Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity
by: Rana Dilara Incebacak Eltemur, et al.
Published: (2022-10-01)

The regulation of circRNA and lncRNAprotein binding in cardiovascular diseases: Emerging therapeutic targets
by: Huilei Zhao, et al.
Published: (2023-09-01)

RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction
by: Victoria A. Cornelius, et al.
Published: (2022-08-01)

RNA-Binding Proteins in Cancer: Functional and Therapeutic Perspectives
by: Donghee Kang, et al.
Published: (2020-09-01)

Prion Formation and Polyglutamine Aggregation Are Controlled by Two Classes of Genes
by: Manogaran, Anita L., et al.
Published: (2011)

The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis
by: Simon Jasinski-Bergner, et al.
Published: (2020-07-01)

Inflammasomes: Role in disease pathogenesis and therapeutic potential
by: E.E. Garanina, et al.
Published: (2020-03-01)

Splicing Modulators Are Involved in Human Polyglutamine Diversification via Protein Complexes Shuttling between Nucleus and Cytoplasm
by: Makoto K. Shimada
Published: (2023-06-01)

Coaggregation of polyglutamine (polyQ) proteins is mediated by polyQ-tract interactions and impairs cellular proteostasis
by: Hong Jun-Ye, et al.
Published: (2023-05-01)

The high-density lipoprotein binding protein HDLBP is an unusual RNA-binding protein with multiple roles in cancer and disease
by: Jonathan Feicht, et al.
Published: (2024-12-01)

Uncoupling the Trade-Off between Somatic Proteostasis and Reproduction in Caenorhabditis elegans Models of Polyglutamine Diseases
by: Anat Ben-Zvi, et al.
Published: (2017-04-01)

RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease
by: Sophia Kelaini, et al.
Published: (2021-04-01)

Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics
by: Yinghuan Cen, et al.
Published: (2023-02-01)

Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation.
by: Iwata, A, et al.
Published: (2005)

Population genetics of spinoсerebellar ataxias caused by polyglutamine expansions
by: A. N. Shuvaev, et al.
Published: (2019-07-01)

Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal
by: Tej Kandola, et al.
Published: (2023-11-01)

Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice
by: Shanshan Huang, et al.
Published: (2015-10-01)

DNA and RNA Binding Proteins: From Motifs to Roles in Cancer
by: Ondrej Bonczek, et al.
Published: (2022-08-01)

Role of Optimization in RNA–Protein-Binding Prediction
by: Shrooq Alsenan, et al.
Published: (2024-02-01)